Synnovis Listed by qilin Ransomware Group: Ransomware Claim — What’s Alleged & What To Do

Ransomware groups continue to target healthcare and diagnostics providers, where operational disruption and sensitive patient data create strong leverage. In this landscape, listings on criminal leak sites have become a common way for attackers to pressure organisations after claiming to have stolen files.

On 4 June 2024, the pathology partnership Synnovis was listed by the ransomware group known as qilin. Public reporting indicates that internal files were exfiltrated in a ransomware attack. The number of people affected remains unknown, and full technical detail about the intrusion has not been disclosed. The listing itself is a claim by the group; independent confirmation of every asserted detail is limited.

What happened

According to available reporting dated 4 June 2024, Synnovis appeared on a leak site associated with the qilin ransomware group. The reported summary states that internal files were exfiltrated in a ransomware attack and that the group indicated data would be made open and available. No public figure has been given for the volume of data, the exact date of initial access, or the technical method used to enter the network. The number of individuals whose information may be involved is listed as unknown. Beyond the claim of exfiltration of internal files and the leak-site listing, further operational specifics remain undisclosed in the public record used for this account.

Who is qilin?

Qilin is a ransomware operation that has been publicly documented as running a ransomware-as-a-service model. Groups of this type typically recruit affiliates who conduct intrusions, deploy encryption, and threaten to publish stolen data unless a ransom is paid—a pattern often described as double extortion. Public reporting on qilin has associated the brand with attacks across multiple sectors and geographies, with leak-site postings used to name victims and, in some cases, to release sample files. In this incident, the group’s listing of Synnovis should be treated as its claim; the facts provided do not independently verify every assertion the group may have made about the victim beyond the reported exfiltration of internal files.

About Synnovis

Synnovis is a pathology partnership involving Guy’s and St Thomas’ NHS Foundation Trust, King’s College Hospital NHS Trust, and SYNLAB, a major European provider of medical testing and diagnostics. Organisations of this kind process laboratory samples, generate diagnostic results, and manage the administrative and clinical data that support hospital and community care pathways. Because pathology services sit close to patient care, any significant disruption or data exposure can affect testing turnaround, clinical decision-making, and the confidentiality of health-related information. A ransomware incident against such a partnership is therefore consequential both for operational continuity and for the people whose records or related files may have been involved.

What was likely exposed

The facts name the exposed material as internal files exfiltrated in a ransomware attack. No further breakdown of file categories, record counts, or specific data fields has been confirmed in the material provided. Pathology and diagnostics organisations typically hold laboratory results, patient identifiers, referral and request details, staff and contractor records, and operational documents. It is not established which of these, if any, were among the files claimed to have been taken. Exact contents remain unconfirmed; readers should treat any detailed inventory as speculative until official notification or verified disclosure is available.

Why it matters

For individuals, exposure of health-related or administrative data can create risks of identity misuse, targeted phishing that references real medical or personal details, and longer-term privacy harm. Even when clinical records are not confirmed as part of a dump, internal files can still contain enough context to enable social engineering. For the organisation and its NHS partners, a ransomware event can interrupt laboratory workflows, delay results, and require costly recovery and notification work. Trust in diagnostic services depends on both availability and confidentiality; an incident of this type therefore carries operational, regulatory, and reputational weight even when the full scale of data loss is still unknown.

If your data was in this claimed breach

If you have used services connected to Synnovis, Guy’s and St Thomas’, King’s College Hospital, or related pathology pathways, treat the situation as a possible exposure until you receive clear official guidance. Practical first steps include:

• Watch for unexpected emails, texts, or calls that reference medical tests, appointments, or personal details; verify any request through official channels rather than links in the message.
• Enable multi-factor authentication on email, patient portals, and financial accounts where available, and change passwords that may have been reused.
• Monitor bank and credit activity for unusual behaviour and consider fraud alerts if you believe sensitive identifiers were involved.
• Retain any formal notification you receive from the organisation or authorities; it will state what was confirmed and what support is offered.
• You can run a free exposure scan of your email address to check whether that address has already appeared in known breach datasets elsewhere.

Public detail on this incident remains limited. Rely on official statements from Synnovis and the relevant NHS trusts for confirmed scope, and avoid acting on unverified dumps or secondary claims until they are independently assessed.

AICompiled with AI assistance from public sources and published under our editorial standards.